Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adult muscle-type nicotinic acetylcholine receptor (nAChR) is a heteropentameric ligand-gated ion channel located at the postsynaptic membrane of the neuromuscular junction [StatPearls, 2023]. It is composed of two alpha-1, one beta-1, one delta, and one epsilon subunit, a configuration that distinguishes the adult form from the fetal gamma-containing isoform [UniProt, 2024]. The receptor's primary biological role is to mediate neuromuscular transmission by opening an internal pore in response to acetylcholine binding, which allows the flow of cations (sodium, potassium, and calcium) and leads to muscle fiber depolarization and contraction [StatPearls, 2023]. In clinical practice, this receptor is the primary target for non-depolarizing neuromuscular blocking agents like rocuronium, which competitively inhibit acetylcholine binding to induce skeletal muscle relaxation during surgery and intubation [StatPearls, 2023]. Dysfunction of this receptor is also central to autoimmune conditions such as myasthenia gravis, where antibodies target the receptor subunits, leading to impaired transmission and muscle weakness [NIH, 2022].
Competitive antagonism of the acetylcholine binding sites on the alpha-1 subunits of the receptor, preventing ion channel opening and subsequent muscle depolarization [StatPearls, 2023].
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adult muscle-type nicotinic acetylcholine receptor (nAChR).